---
title: "Ergothioneine concept stocks attract attention, multiple companies respond"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/240731875.md"
description: "Recently, ergotamine concept stocks have attracted attention, and several companies have responded to related questions on interactive platforms. Chengzhi stated that ergotamine is still in the small-scale testing phase; SIRIO's U.S. subsidiary has the capability to produce NAD+ ergotamine capsules and is optimistic about the anti-aging market; WanBang Pharmaceutical provides clinical trial services for ergotamine eye wash; FUSHILAI stated that there is currently no related business"
datetime: "2025-05-19T01:02:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/240731875.md)
  - [en](https://longbridge.com/en/news/240731875.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/240731875.md)
generator: "portal-rs"
---

# Ergothioneine concept stocks attract attention, multiple companies respond

Recently, ergotamine concept stocks have emerged strongly, with several listed companies responding to related questions on interactive platforms. ① Chengzhi: The company's ergotamine is still in the small-scale testing phase. ② SIRIO: The company's U.S. subsidiary Best Formulations has the capability to produce NAD+ ergotamine cell energy capsules. The company is very optimistic about the development potential of the anti-aging market. In addition to ergotamine, the company has also laid out related products such as PQQ, quercetin, and Q10 that can be applied in anti-aging scenarios. In February of this year, the company announced the establishment of an anti-aging research institute, aiming to focus on "scientific research innovation + industrial transformation," with a focus on four major areas: cellular systems, probiotics and the gut, muscle joints, and women's ovaries. ③ WanBang Pharmaceutical: The company provides clinical efficacy testing services for an ergotamine eye wash project aimed at improving dry eye syndrome. ④ FUSHILAI: The company currently has no ergotamine-related business

### Related Stocks

- [000990.CN](https://longbridge.com/en/quote/000990.CN.md)
- [301258.CN](https://longbridge.com/en/quote/301258.CN.md)
- [300791.CN](https://longbridge.com/en/quote/300791.CN.md)
- [301520.CN](https://longbridge.com/en/quote/301520.CN.md)

## Related News & Research

- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [UNM and ScienceSoft Launch First Statewide WHO Healthy Aging Initiative in US](https://longbridge.com/en/news/296641162.md)
- [CDC lifts beneficial stake in Exosens to 11.71% of capital, 13.87% of voting rights](https://longbridge.com/en/news/296499698.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)
- [REG - Cloudcoco Group PLC - Director/PDMR Shareholding](https://longbridge.com/en/news/296131812.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**